Danaher (NYSE:DHR) had its price target lifted by analysts at Credit Suisse Group from $282.00 to $288.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the conglomerate’s stock. Credit Suisse Group’s target price points to a potential upside of 11.98% from the stock’s previous close.
A number of other brokerages have also weighed in on DHR. Robert W. Baird increased their target price on shares of Danaher from $249.00 to $270.00 and gave the stock an “outperform” rating in a research report on Friday, April 23rd. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised their target price on shares of Danaher from $275.00 to $315.00 in a research note on Friday, April 23rd. Wells Fargo & Company lifted their target price on shares of Danaher from $260.00 to $280.00 and gave the stock an “overweight” rating in a research note on Friday, April 23rd. Citigroup boosted their target price on shares of Danaher from $275.00 to $315.00 in a report on Friday, April 23rd. Finally, Jefferies Financial Group lifted their price target on Danaher from $270.00 to $290.00 and gave the stock a “buy” rating in a research report on Friday, April 23rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $271.93.
NYSE DHR traded up $0.10 on Friday, hitting $257.18. 17,404 shares of the company were exchanged, compared to its average volume of 2,567,498. The stock has a market capitalization of $183.44 billion, a P/E ratio of 40.50, a PEG ratio of 1.54 and a beta of 0.69. Danaher has a 12 month low of $168.59 and a 12 month high of $261.43. The stock’s fifty day moving average is $249.79. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.70 and a current ratio of 2.05.
Danaher (NYSE:DHR) last announced its earnings results on Wednesday, April 21st. The conglomerate reported $2.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.67 by $0.85. The company had revenue of $6.87 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 19.17% and a return on equity of 16.34%. The firm’s revenue for the quarter was up 58.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.05 earnings per share. As a group, research analysts anticipate that Danaher will post 8.93 earnings per share for the current year.
In other Danaher news, SVP Angela S. Lalor sold 3,092 shares of the company’s stock in a transaction dated Friday, April 23rd. The stock was sold at an average price of $255.79, for a total transaction of $790,902.68. Following the sale, the senior vice president now owns 30,937 shares in the company, valued at approximately $7,913,375.23. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Joakim Weidemanis sold 17,169 shares of the company’s stock in a transaction dated Tuesday, April 27th. The stock was sold at an average price of $258.76, for a total value of $4,442,650.44. Following the sale, the executive vice president now owns 84,420 shares in the company, valued at approximately $21,844,519.20. The disclosure for this sale can be found here. Insiders sold a total of 35,165 shares of company stock worth $9,051,818 in the last quarter. Company insiders own 11.40% of the company’s stock.
Several large investors have recently added to or reduced their stakes in the company. Advisory Services Network LLC boosted its position in shares of Danaher by 68.1% in the 4th quarter. Advisory Services Network LLC now owns 8,712 shares of the conglomerate’s stock valued at $1,935,000 after purchasing an additional 3,530 shares during the period. Cambridge Investment Research Advisors Inc. grew its holdings in Danaher by 4.2% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 62,313 shares of the conglomerate’s stock valued at $14,025,000 after buying an additional 2,507 shares during the last quarter. Rafferty Asset Management LLC boosted its holdings in shares of Danaher by 9.6% during the first quarter. Rafferty Asset Management LLC now owns 12,826 shares of the conglomerate’s stock worth $2,887,000 after purchasing an additional 1,123 shares during the last quarter. Gilbert & Cook Inc. boosted its holdings in shares of Danaher by 15.3% during the fourth quarter. Gilbert & Cook Inc. now owns 1,979 shares of the conglomerate’s stock worth $438,000 after purchasing an additional 263 shares during the last quarter. Finally, Standard Life Aberdeen plc boosted its holdings in shares of Danaher by 16.3% during the first quarter. Standard Life Aberdeen plc now owns 306,013 shares of the conglomerate’s stock worth $68,915,000 after purchasing an additional 42,930 shares during the last quarter. 77.57% of the stock is owned by institutional investors and hedge funds.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Why do analysts give a neutral rating?